BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32279670)

  • 1. The impact of changing reflexive to clinician-ordered
    Sullivan EL; Majumdar R; Ortiz C; Riggs PK; Crum-Cianflone NF
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):684-690. PubMed ID: 32279670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
    Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
    Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
    Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and outcomes of
    Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
    Catanzaro M; Cirone J
    Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis.
    Kociolek LK; Bovee M; Carter D; Ciolino JD; Patel R; O'Donnell A; Rupp AH; Zheng X; Shulman ST; Patel SJ
    J Pediatric Infect Dis Soc; 2017 Jun; 6(2):142-148. PubMed ID: 27190172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection.
    Mah R; Locher K; Steiner TS; Stefanovic A
    Anaerobe; 2023 Aug; 82():102755. PubMed ID: 37406762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
    Cook PP; Nichols S; Coogan M; Opera J; DeHart M
    Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
    Alnimr A; Alwazzeh MJ; Al-Ameer A
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
    Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile.
    Guinta MM; Bunnell K; Harrington A; Bleasdale S; Danziger L; Wenzler E
    Ann Clin Microbiol Antimicrob; 2017 Dec; 16(1):77. PubMed ID: 29202797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
    Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
    J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
    Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
    J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship.
    Dbeibo L; Lucky CW; Fadel WF; Sadowski J; Beeler C; Kelley K; Williams J; Webb D; Kara A
    Clin Microbiol Infect; 2023 Jun; 29(6):798.e1-798.e4. PubMed ID: 36804907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
    Longtin Y; Trottier S; Brochu G; Paquet-Bolduc B; Garenc C; Loungnarath V; Beaulieu C; Goulet D; Longtin J
    Clin Infect Dis; 2013 Jan; 56(1):67-73. PubMed ID: 23011147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical heterogeneity of patients with stool samples testing PCR+/Tox- from a two-step Clostridium difficile diagnostic algorithm.
    Zou J; Leung V; Champagne S; Hinch M; Wong A; Lloyd-Smith E; Nguyen TT; Romney MG; Sharma A; Payne M; Lowe CF
    Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2355-2359. PubMed ID: 30238342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a multipronged approach to reduce the incidence of Clostridioides difficile infections in hospitalized patients.
    Katzman M; Cohrs AC; Hnatuck PE; Greene WH; Reed SM; Ward MA; Glasser FD; Loser MF; Hale CM
    Am J Infect Control; 2023 Jun; 51(6):668-674. PubMed ID: 36075295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent Class Analysis for the Diagnosis of Clostridioides difficile Infection.
    Doolan CP; Louie T; Lata C; Larios OE; Stokes W; Kim J; Brown K; Beck P; Deardon R; Pillai DR
    Clin Infect Dis; 2021 Nov; 73(9):e2673-e2679. PubMed ID: 33053174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.